PART 1: GENERAL PRINCIPLES
- An overview of imaging in oncology
- Trends in cancer incidence, survival and mortality
- Staging of cancer
- Multidisciplinary treatment of cancer: surgical, chemotherapy and radiotherapy
- Assessment of response to treatment
- Second malignancies
PART 2: PRIMARY TUMOUR EVALUATION AND STAGING
- Lung cancer
- Mediastinal tumours
- Pleural tumours
- Oesophageal cancer
- Gastric cancer
- Colorectal cancer
- Primary tumours of the liver and biliary tract
- Renal tumours
- Primary adrenal malignancy
- Pancreatic malignancy
- Bladder cancer
- Prostate cancer
- Testicular germ cell tumours
- Ovarian cancer
- Uterine and cervical tumours
- Primary retroperitoneal tumours
- Primary bone tumours
- Soft tissue sarcomas
- Breast cancer
- Paranasal sinus neoplasms
- Tumours of the pharynx, tongue and mouth
- Laryngeal tumours
- Thyroid cancer
- Primary tumours of the central nervous system
- Neuroendocrine tumours
PART 3: HAEMATOLOGICAL MALIGNANCY
- Lymphoma
- Multiple myeloma
- Leukaemia
PART 4: PAEDIATRICS
- General principles in paediatric oncology
- Wilm’s tumour and associated neoplasms of the kidney
- Neuroblastoma
- Uncommon paediatric neoplasms
PART 5: METASTASES
- Lymph node metastases (including MR lymphography)
- Lung and pleural metastases
- Bone metastases
- The liver
- Metastatic effects on the nervous system
- Adrenal metastases
- Pertoneal metastases
- Spleen
- Malignant tumours of the skin
- Padiological investigation of carcinoma of unknown primary site
PART 6: IMAGING AND TREATMENT
- Interventional imaging: general applications
- Interventional imaging: tumour ablation
- Imaging for radiotherapy treatment planning
- Radiological manifestations of acute complications of treatment
PART 7: EFFECTS OF TREATMENT ON NORMAL TISSUE
- Thorax
- Bone and bone marrow
- Abdomen and pelvis
PART 8: THE IMMUNOCOMPROMISED HOST
- The immunocompromised host: clinical considerations
- The immunocompromised host: central nervous system
- The immunocompromised host: chest
- The immunocompromised host: abdomen and pelvis
PART 9: FUNCTIONAL IMAGING
- Clinical implications
- CT
- MRI
- PET
Janet Husband, Royal Marsden Hospital, London, UK
Formerly Professor of Diagnostic Radiology, University of London Institute of Cancer Research and Consultant Radiologist at The Royal Marsden NHS Foundation Trust. She was President of the Royal College of Radiologists 2004-2007, and Past President of the British Institute of Radiology, 2003-2004. Dame Janet was Vice-President of the Academy of Medical Royal Colleges and an elected member of the General Medical Council. During 30 years of service at The Royal Marsden Dame Janet led pioneering clinical research both in CT and MRI in cancer care. In the Queen's Birthday Honours 2007, was appointed Dame Commander of the Most Excellent Order of the British Empire for services to medicine.
Rodney Reznek, Saint Bartholomew’s Hospital, London, UK
Joined Barts and the London School of Medicine in 1977 as a registrar and, in 1996, was appointed as Professor of Diagnostic Imaging. His work focuses on the use of magnetic resonance imaging and computer topography in the diagnosis, prognosis and treatment of cancer, particularly gynaecological, abdominal, and endocrine cancer. With Professor Janet Husband, he co-founded the International Cancer Imaging Society in 1998 and was its President from 2001-2002.

